LabVantage Solutions® Awarded Frost & Sullivan’s “2014 Company of the Year”
News Dec 09, 2014
LabVantage Solutions has been awarded the prestigious 2014 North American Laboratory Information Management Systems (LIMS) Company of the Year Award by research firm, Frost & Sullivan.
Frost & Sullivan presents this award to a company that is a true industry leader, and consistently demonstrates best practices in growth, innovation, customer focus and leadership. This award recognizes LabVantage's exemplary focus on delivering the best products and services that maximize value to the customer and enhance the customer experience.
After an extensive evaluation process, LabVantage was selected as the “top competitor” in the LIMS market. Criteria included a unique ability to cater to broad industry needs, unmatched flexibility applicable to a variety of markets and excellence in customer care. Key considerations for the award were the quality and range of the overall product line, price/performance value and customer purchase experience, financial performance, and implementation best practices. According to Frost & Sullivan, “LabVantage is a key player in many of the markets with a much superior Web-based product that is far more efficient and flexible than competing products.”
Peter Bailey, LabVantage CEO, stated, "We are truly honored to be recognized by Frost & Sullivan, a global leader in analyzing markets, industry trends, and best practices. This Best Practices Award highlights our innovation in laboratory sciences and our commitment to remain the premier global partner for advancing research, science and quality through informatics. Ultimately, our leadership position is a great testament to the strength of our technology, and reflects how the hard work and commitment of our global team drives value for our customers."
HIV-1 replicates in ninja-like ways. The virus slips through the membrane of vital white blood cells. Inside, HIV-1 copies its genes and scavenges parts to build a protective bubble for its copies. Now, supercomputers have helped model a key building block in the HIV-1 protective capsid, which could lead to strategies for potential therapeutic intervention in HIV-1 replication.READ MORE